Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12605448 | Porous self-healing polymer matrix for encapsulation of active macromolecules and methods | 🖼🧊📄§ | 2026-04-21 | 2040-07-20 | 0 | 31 |
| 12605449 | Drug-clay mineral complex containing phospholipid and oral administration composition including same | 🖼🧊📄§ | 2026-04-21 | 2041-07-01 | 0 | 31 |
| 12606614 | Human FcRn-binding modified antibodies and methods of use | 🖼🧊📄§ | 2026-04-21 | 2041-07-12 | 0 | 31 |
| 12606526 | Substituted salicylamide compounds and use thereof | 🖼🧊📄§ | 2026-04-21 | 2042-01-10 | 0 | 31 |
| 12605396 | Methods of treating mastitis with an orthosomycin antimicrobial compound | 🖼🧊📄§ | 2026-04-21 | 2041-12-23 | 0 | 31 |
| 12605324 | Composition comprising ingredients for DIC-gel and polyol | 🖼🧊📄§ | 2026-04-21 | 2040-06-02 | 0 | 31 |
| 12605368 | Suppression of neuroinflammation and composition and method therefor | 🖼🧊📄§ | 2026-04-21 | 2041-03-31 | 0 | 31 |
| 12605369 | Amido-substituted heterocyclic compounds and methods of use thereof for the treatment of herpes viruses | 🖼🧊📄§ | 2026-04-21 | 2040-12-16 | 0 | 31 |
| 12605370 | Agents and compositions for the treatment of glioblastoma | 🖼🧊📄§ | 2026-04-21 | 2041-03-12 | 0 | 31 |
| 12605371 | Combination therapy for cancer | 🖼🧊📄§ | 2026-04-21 | 2041-07-26 | 0 | 31 |
| 12605372 | Combination therapy for the treatment of cancer | 🖼🧊📄§ | 2026-04-21 | 2042-11-09 | 0 | 31 |
| 12605381 | Method for treating endometriosis-associated pain by using diaminopyrimidine compound | 🖼🧊📄§ | 2026-04-21 | 2040-04-29 | 0 | 31 |
| 12605382 | Pharmaceutical composition for preventing, alleviating, or treating cancer containing 2,6-dichloro-4-(4-(4-hydroxycyclohexylamino)-7H- pyrrolo[2,3-d]pyrimidin-5-yl)phenol as active ingredient | 🖼🧊📄§ | 2026-04-21 | 2042-05-03 | 0 | 31 |
| 12605385 | Methotrexate formulation | 🖼🧊📄§ | 2026-04-21 | 2043-09-28 | 0 | 31 |
| 12605386 | Sapropterin formulation | 🖼🧊📄§ | 2026-04-21 | 2045-07-16 | 0 | 31 |
| 12605387 | Treatment of cancers using PI3 kinase isoform modulators | 🖼🧊📄§ | 2026-04-21 | 2040-07-24 | 0 | 31 |
| 12605398 | CRISPR-based compositions for treating vascular disorders | 🖼🧊📄§ | 2026-04-21 | 2040-01-27 | 0 | 31 |
| 12605434 | Composition for preventing or treating autoimmune diseases | 🖼🧊📄§ | 2026-04-21 | 2042-09-13 | 0 | 31 |
| 12605450 | C3-carbon linked glutarimide Degronimers for target protein degradation | 🖼🧊📄§ | 2026-04-21 | 2044-04-22 | 0 | 31 |
| 12607406 | Recombinant virus, composition comprising the same, and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2044-08-14 | 0 | 31 |
| 12605349 | Methods of treating grade 3 astrocytoma | 🖼🧊📄§ | 2026-04-21 | 2044-12-11 | 0 | 31 |
| 12606936 | Compositions and methods for making novel T-cell receptors | 🖼🧊📄§ | 2026-04-21 | 2042-07-12 | 0 | 31 |
| 12606564 | Adenosine receptor antagonist compounds | 🖼🧊📄§ | 2026-04-21 | 2040-11-19 | 0 | 31 |
| 12606570 | Deuterated compounds and imaging agents for imaging huntingtin protein | 🖼🧊📄§ | 2026-04-21 | 2042-04-26 | 0 | 31 |
| 12606594 | Heterotandem bicyclic peptide complexes | 🖼🧊📄§ | 2026-04-21 | 2042-02-02 | 0 | 31 |
| 12606596 | Self-assembling insect ferritin nanoparticles | 🖼🧊📄§ | 2026-04-21 | 2044-03-25 | 0 | 31 |
| 12606610 | Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes | 🖼🧊📄§ | 2026-04-21 | 2043-08-16 | 0 | 31 |
| 12606609 | Polypeptides having improved properties | 🖼🧊📄§ | 2026-04-21 | 2041-01-26 | 0 | 31 |
| 12606606 | Nucleic acid construct that encodes chimeric rhodopsin | 🖼🧊📄§ | 2026-04-21 | 2040-09-11 | 0 | 31 |
| 12606615 | Anti-FGF23 antibody or antibody fragment thereof | 🖼🧊📄§ | 2026-04-21 | 2044-11-29 | 0 | 31 |
| 12606617 | Composition comprising an IgE antibody | 🖼🧊📄§ | 2026-04-21 | 2041-04-23 | 0 | 31 |
| 12606616 | PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer | 🖼🧊📄§ | 2026-04-21 | 2045-12-08 | 0 | 31 |
| 12606633 | Methods and compositions for anti-CD73 antibodies and variants | 🖼🧊📄§ | 2026-04-21 | 2042-01-25 | 0 | 31 |
| 12606634 | Antibody-pyrrolobenzodiazepine derivative conjugate which binds caludin-6 and claudin-9 | 🖼🧊📄§ | 2026-04-21 | 2044-04-08 | 0 | 31 |
| 12606632 | Anti-CD40 antibodies and methods of use | 🖼🧊📄§ | 2026-04-21 | 2043-03-13 | 0 | 31 |
| 12606638 | Dosing regimens for use with PCSK9 inhibitors | 🖼🧊📄§ | 2026-04-21 | 2043-04-17 | 0 | 31 |
| 12606641 | Amphiphilic carbohydrate compounds | 🖼🧊📄§ | 2026-04-21 | 2041-05-21 | 0 | 31 |
| 12606805 | Tymovirus virus and virus-like particles as nanocarriers for imaging and therapeutic agents | 🖼🧊📄§ | 2026-04-21 | 2043-08-29 | 0 | 31 |
| 12606804 | Influenza virus backbone | 🖼🧊📄§ | 2026-04-21 | 2041-07-21 | 0 | 31 |
| 12606833 | Modified mini-nucleosome core proteins and use in nucleic acid delivery | 🖼🧊📄§ | 2026-04-21 | 2041-04-12 | 0 | 31 |
| 12606571 | Macrocyclic compounds and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2044-04-09 | 0 | 31 |
| 12606534 | Method for the treatment of keratin materials using acid, ester or amide C-glycoside derivatives, and cosmetic composition containing same | 🖼🧊📄§ | 2026-04-21 | 2037-11-07 | 0 | 31 |
| 12606535 | Gas phase methods to extract natural products | 🖼🧊📄§ | 2026-04-21 | 2041-02-08 | 0 | 31 |
| 12606826 | Modulation of transthyretin expression | 🖼🧊📄§ | 2026-04-21 | 2042-12-02 | 0 | 31 |
| 12606827 | Compounds for treatment of osteoarthritis | 🖼🧊📄§ | 2026-04-21 | 2043-05-19 | 0 | 31 |
| 12606620 | Anti-LILRB1 antibody and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2041-07-27 | 0 | 31 |
| 12606639 | Antigen binding proteins | 🖼🧊📄§ | 2026-04-21 | 2045-05-20 | 0 | 31 |
| 12605486 | Afibrotic compounds, devices, and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2039-03-01 | 0 | 31 |
| 12605472 | Radiolabeling of anti-CD45 immunoglobulin and methods of use thereof | 🖼🧊📄§ | 2026-04-21 | 2040-09-17 | 0 | 31 |
| 12605471 | Cromolyn derivatives and related methods of imaging and treatment | 🖼🧊📄§ | 2026-04-21 | 2043-06-02 | 0 | 31 |